Company news

Clever Culture Systems Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Proposed issue of securities - CC5

November 2, 2026

Funding Raised for Development of a New Benchtop Instrument

November 2, 2026

Funding Raised for Development of a New Benchtop Instrument

November 2, 2026

Trading Halt

October 29, 2026

Trading Halt

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Change of Registry Address Notification

October 29, 2026

Advancing Sales Pipeline Underpins Growth Momentum

October 27, 2026

Advancing Sales Pipeline Underpins Growth Momentum

October 27, 2026

PSC Biotech Partnership Expands US Pharma Sales Reach

October 13, 2026

Proposed issue of securities - CC5

October 13, 2026

Proposed issue of securities - CC5

October 13, 2026

Notice of Annual General Meeting/Proxy Form

October 13, 2026

Novo Nordisk Expand Use of APAS Independence

September 6, 2026

Appendix 4G

August 30, 2026

Corporate Governance Statement

August 30, 2026

Annual Report to shareholders

August 30, 2026

Appendix 4E

August 30, 2026

Application for quotation of securities - CC5

August 13, 2026

Change of Director's Interest Notice

August 12, 2026

Notification of cessation of securities - CC5

August 9, 2026

Proposed issue of securities - CC5

August 5, 2026

Proposed issue of securities - CC5

August 5, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

July 29, 2026

Half Yearly Report and Accounts

February 16, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 27, 2026

Appendix 4E

August 28, 2025

APAS Contact Plate Application Product Launch

August 26, 2025

Instrument Sale to Novo Nordisk for Group Evaluation

July 13, 2025

Additional Four Instruments Ordered by AstraZeneca

December 4, 2024

LBT Announce Bristol Myers Squibb Purchase APAS Independence

October 21, 2024

Astrazeneca sale & service contract up to a$4.1M

August 6, 2024

Response to ASX Price Query

June 13, 2024

Lift of Pause in Trading

June 13, 2024

Pause in Trading

June 13, 2024

Apas pharmaqc sale to novacina

April 28, 2024

APAS PharmaQC Commercially Ready - Performance Finalised

March 12, 2024

Delivery Completes First Sale of APAS PharmaQC

February 21, 2024

Placement Completes Financial Restructure

November 19, 2023

Renounceable Rights Issue Results

November 15, 2023

$1.7M SA Government Loan Restructure

November 5, 2023

Entitlement Offer Underwriting Increased to $3.6M

October 26, 2023

Prospectus

October 12, 2023

$4.5 million Entitlement Offer

October 12, 2023

Full Repayment of $1.38M Share Placement Facility

October 12, 2023

Preliminary Annual Financial Report & Appendix 4E

August 30, 2023

Non-Cash Impairment of Intangible Assets

August 3, 2023

Placement Supports APAS Pharma & EU Expansion

March 19, 2023

AstraZeneca Partners LBT for APAS Pharma Development

January 8, 2023

Older news releases →

Decks

The 5 newest of 12 decks. Every deck is listed under its year.